FDA Inspection 1081255 — West Therapeutics Development, LLC
The FDA completed an inspection of West Therapeutics Development, LLC on Dec 6, 2018 in Grayslake, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 6, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Grayslake, IL (United States)
Additional Details
Risk Evaluation and Mitigation Strategies (REMS)